Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort.

Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort.. Alessi, Marie-Christine; Nicaud, Viviane; Scroyen, Ilse; Lange, Celine; Saut, Noemie; Fumeron, Frederic; Marre, Michel; Lantieri, Olivier; Fontaine-Bisson, Benedicte; Juhan-Vague, Irene; Balkau, Beverley; Tregouet, David-Alexandre; Morange, Pierre-Emmanuel. Thrombosis and haemostasis. 2011; 416-422: p.416-422. doi:10.1160/TH11-03-0179
    Article